http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010265323-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da04b40384f30a62c8c906c771d576f6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2010-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e1fe87346f839a9d18c9e8d6268821f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104cd095eb14aee240c588350c74c092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57f3574e2fd1f1009c754e6cb0f5a3be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a01ed0463650e0e4d5a68d0d57228be |
publicationDate | 2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2010265323-A |
titleOfInvention | PSCA: Prostate stem cell antigen and uses thereof |
abstract | PROBLEM TO BE SOLVED: Prostate stem cell antigen (PSCA) is widely overexpressed in all stages of prostate cancer, including a high degree of prostate intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors, To provide a novel prostate cell surface antigen. A method for extending the life of a patient having a cancer associated with PSCA, wherein the amount of the antibody selectively binds to PSCA for a time sufficient to inhibit the growth of the cancer cells. A method comprising administering an antibody to a subject, thereby extending the life of the subject. [Selection figure] None |
priorityDate | 1999-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1691.